Dr. Raina

Komal Raina

Associate Professor/Haarberg Chair in Cancer Research

Education

Academic and Professional Experience

Academic Interests
Academic Interests
  • Cancer prevention
  • Intervention research
Committees and Professional Memberships
  • 2005-present: associate member of American Association of Cancer Research (AACR)
  • 2014-October 2018: associate member, University of Colorado Cancer Center
  • November 2018-present: adjoint research faculty, School of Pharmacy, UC Denver-AMC Aurora, Colorado
  • January 2019-present: editorial board member: Associate Editor-Molecular Carcinogenesis (Wiley Periodicals, Inc.)
Work Experience
  • October 1997-July 1999: research associate, R&D, Ranbaxy Research Laboratories, India
  • November 1999-April 2005: senior research associate, The Talwar Research Foundation, New Delhi, India
  • May 2005-October 2008: visiting research associate, School of Pharmacy, University of Colorado Denver, Denver
  • November 2008-April 10: research associate, School of Pharmacy, University of Colorado Denver (AMC), Aurora, Colorado
  • November 2010- June 2011: research associate, School of Pharmacy, University of Colorado Denver (AMC), Aurora, Colorado
  • July 2011-December 2013: research instructor, School of Pharmacy, University of Colorado Denver (AMC), Aurora, Colorado
  • January 2014-October 2018: assistant professor-research, University of Colorado Denver (AMC), Aurora, Colorado
  • October 2018-present: associate professor/ Haarberg Chair in Cancer Research, College of Pharmacy, South à£à£Ö±²¥Ðã State University
  • November 2018-present: adjoint research faculty, School of Pharmacy, UC Denver-AMC Aurora, Colorado

Research and Scholar Work

Areas of Research
  • Cancer prevention/intervention research-targeting epithelial cancers (prostate, colon, lung and pancreas)
Patents
  1. Talwar GP, Gupta JC, Raina Komal. Recombinant anti-LHRH vaccines for control of sex hormones dependant pathologies in humans and for control of estrus in female mammals and improve meat quality in male à£à£Ö±²¥Ðãs. WTO Product Patent, 2003, Application No. 768/DEL/2003.
  2. Talwar GP, Gupta JC, Raina Komal. A method of reducing levels of sex steroid hormones in mammals by using recombinant anti-LHRH vaccines. Indian Process patent, 2003. Application No.767/DEL/2003.
Mailing Address:
Avera Health & Science 267
Pharmaceutical Sciences-Box 2202C
University Station
Brookings, SD 57007
Office Location:
Avera Health and Science Center
Room 267
Back to Directory
Related Links